Feedback

Feedback FCF Yield

The Free Cash Flow Yield of Feedback (FDBK.L) as of Nov 4, 2026 is -60.97 %. In the previous year, Free Cash Flow Yield was -48.08 % — a change of 26.82% (lower).

FCF Yield

-60.97 %

YoY

26.82%

Last updated:

Free Cash Flow Yield of Feedback is 2025 -60.97 % . Free Cash Flow Yield of Feedback was 2024 -48.08 % . It decreases by 26.82% lower compared to the previous year.

The Feedback FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
-7.83 GBP
Jan 1, 2019
-21.24 GBP
Jan 1, 2020
-35.94 GBP
Jan 1, 2021
-74.67 GBP
Jan 1, 2022
-51.81 GBP
Jan 1, 2023
-64.32 GBP
Jan 1, 2024
-48.08 GBP
Jan 1, 2025
-60.97 GBP
The Feedback FCF Yield history
YEARFCF YieldYoY
-60.97 %+26.82%
-48.08 %-25.25%
-64.32 %+24.14%
-51.81 %-30.62%
-74.67 %+107.77%
-35.94 %+69.18%
-21.24 %+171.17%
-7.83 %+288.94%
-2.01 %-54.41%
-4.42 %-68.48%
-14.02 %+32.59%
-10.57 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Feedback Stock analysis

What does Feedback do? Feedback PLC provides imaging tools for clinical decision makers, including TexRAD for medical research and clinical trial management, and Cadran for medical imaging decision support. The company offers Cadran Image Storage Management for image display, review, and enterprise archiving across clinical, non-clinical, and teaching environments. Subsidiaries such as Feedback Black Box Company Limited, Feedback Data GmbH, Brickshield Limited, Cambridge Computed Imaging Limited, TexRAD Limited, and Prostate Checker Ltd support its operations. The firm generates revenue through these products and services targeting medical practitioners, researchers, and pharmaceutical companies involved in cancer detection and treatment workflows. TexRAD is utilized by pharmaceutical companies for managing clinical trials and research, while Cadran and Cadran Image Storage Management are sold to healthcare providers and institutions requiring advanced imaging solutions. The company’s focus on imaging biomarkers for cancer detection attracts partnerships with medical research organizations and hospitals seeking to improve diagnostic accuracy and patient outcomes. Feedback Data GmbH and TexRAD Limited specifically contribute to the development and management of imaging techniques and workflow solutions for the medical sector. The business model centers on selling specialized imaging software and tools to healthcare institutions, pharmaceutical firms, and research organizations. Products like Cadran Image Storage Management are designed for enterprise-level archiving and image handling, appealing to large healthcare systems and academic institutions. TexRAD’s role in clinical trial management ensures recurring revenue streams from pharmaceutical clients who rely on its platform for trial execution and data management. Feedback is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Feedback stock

Free Cash Flow Yield of Feedback is -60.97 % in 2025.

Free Cash Flow Yield of Feedback changed from -48.08 % to -60.97 %, representing a 26.82% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Feedback since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Feedback with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Feedback

All Key Metrics — Feedback